Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

AGM Statement

20 Mar 2019 07:00

RNS Number : 3317T
Arden Partners plc
20 March 2019
 

Arden Partners plc

("Arden" or the "Company")

 

Annual General Meeting Statement 2019

 

 Arden Partners plc (AIM: ARDN), the institutional stockbroking company, will hold its Annual General Meeting ("AGM") at 12.30 pm today at 125 Old Broad Street, London EC2N 1AR.

 

The following statement will be made at the AGM:

 

"As predicted in the 2018 Annual Report, market conditions have remained challenging and we expect them to continue to be so in the short term.

 

Nevertheless, in the year to date we have completed a number of fundraisings and advisory transactions on behalf of our corporate clients.

 

Furthermore, we have continued to grow our corporate client base which remains key to our strategy.

 

The Company's balance sheet remains strong and despite the market challenges we have a good pipeline of corporate business."

 

For further enquiries:

 

Arden Partners plc

020 7614 5900

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

GCA Altium Limited

020 7484 4040

Sam Fuller / Tim Richardson

 

 

Notes for editors

 

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUKVURKVAOAAR
Date   Source Headline
2nd Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
31st May 201611:50 amRNSForm 8.5 (EPT/NON-RI)
27th May 201611:50 amRNSForm 8.5 (EPT/NON-RI)
26th May 201611:50 amRNSForm 8.5 (EPT/NON-RI)
25th May 201611:50 amRNSForm 8.5 (EPT/NON-RI)
24th May 201612:01 pmRNSForm 8.5 (EPT/NON-RI)
23rd May 201612:23 pmRNSForm 8.5 (EPT/NON-RI) Amendment
23rd May 201612:01 pmRNSForm 8.5 (EPT/NON-RI)
23rd May 201610:44 amRNSBlock Listing Six Monthly Return
22nd Apr 201611:50 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20162:52 pmRNSTransaction in Own Shares and Total Voting Rights
7th Mar 20162:44 pmRNSResult of AGM
7th Mar 20161:58 pmRNSAGM Statement
12th Feb 20161:47 pmRNSBlocklisting Six Monthly Return
4th Feb 20163:42 pmRNSPublication of Annual Report and Notice of AGM
28th Jan 20167:01 amRNSPreliminary Results - Year Ended 31 October 2015
28th Jan 20167:00 amRNSDirectorate Change
23rd Nov 20159:14 amRNSBlocklisting Six Monthly Return
8th Sep 201510:35 amRNSDirector's Dealing
27th Aug 201512:52 pmRNSTransaction in Own Shares and Total Voting Rights
12th Aug 201512:05 pmRNSBlocklisting Six Monthly Return
12th Aug 201512:02 pmRNSTransaction in Own Shares
5th Aug 20151:13 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20157:00 amRNSInterim Results - Six Months Ended 30 April 2015
22nd May 201510:26 amRNSBlocklisting Six Monthly Return
21st Apr 20159:14 amRNSDirectorate Change
19th Mar 201512:08 pmRNSResult of AGM
19th Mar 20157:00 amRNSAGM Statement
19th Feb 20152:08 pmRNSDirectorate Change
13th Feb 20157:00 amRNSNotice of AGM
12th Feb 201510:01 amRNSBlocklisting Six Monthly Return
2nd Feb 201510:57 amRNSTotal Voting Rights
23rd Jan 20155:46 pmRNSHolding(s) in Company
22nd Jan 20153:16 pmRNSHolding(s) in Company
22nd Jan 20153:12 pmRNSHolding(s) in Company
22nd Jan 20153:11 pmRNSHolding(s) in Company
22nd Jan 20153:06 pmRNSHolding(s) in Company
22nd Jan 20153:04 pmRNSHolding(s) in Company
22nd Jan 20151:23 pmRNSTransaction in Own Shares, TVR & Directors Dealing
19th Jan 201510:06 amRNSPublication of Accounts - January 19th, 2015
14th Jan 20157:00 amRNSPreliminary Results - Year Ended 31 October 2014
24th Nov 201411:39 amRNSBlocklisting Six Monthly Return
3rd Nov 20149:39 amRNSTotal Voting Rights
12th Aug 20149:24 amRNSBlocklisting Six Monthly Return - August 12th 2014
31st Jul 20147:00 amRNSInterim Results - Six Months Ended 30 April 2014
2nd Jun 201411:35 amRNSTotal Voting Rights
22nd May 201410:59 amRNSBlocklisting Six Monthly Return
20th Mar 201411:55 amRNSResult of AGM
20th Mar 201410:58 amRNSAGM Statement
10th Mar 20144:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.